National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Stiripentol (Diacomit®) for use in conjunction with clobazam and valproate as adjunctive therapy of
refractory generalized tonic-clonic seizures in patients with severe myoclonic epilepsy in infancy
(SMEI, Dravet’s syndrome) whose seizures are not adequately controlled with clobazam and
valproate

Rapid Review Process
Completed
Rapid review received 06/07/2017
Rapid review completed 10/08/2017
Rapid Review outcome Full pharmacoeconomic assessment recommended
Full pharmacoeconomic assessment commissioned by HSE 04/09/2017
Current Status Awaiting applicant submission